Company intelligence / Profile preview

Pathology

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

PathAI is advancing patient outcomes by leveraging AI in pathology, enhancing diagnostic accuracy and efficiency. Its AISight platform is used for digital pathology workflows and has received FDA clearance for primary diagnosis.

Therapeutic areas: OncologyImmunology
Modalities: AI-powered Digital Pathology Tools
Industry: Pathology

Partnerships

Collaborations with biopharma companies for clinical trials and drug development.Notable partners include Quest Diagnostics and Moffitt Cancer Center.

Beyond the preview

Go deeper on Pathology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathology.

Explore the full profile